NSE: SRF | BSE: 503806

Mid-range Performer

Download real time

2874.70 -14.60 (-0.51%)

275.2K NSE+BSE Volume

NSE 17 Jul, 2026 3:31 PM (IST)

85,213.2

Market Cap

Market Runner Up

Beta 1Year

Very High Volatility

Board Meeting

The next board meeting for SRF is on 22 Jul 2026 for the purpose of Quarterly Results & Interim Dividend See details

SRF Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SRF, BSE:503806 SRF Ltd.

Search Inside the pdf :

SRF Ltd.

24 Jun 2026

2874.70

-0.51%

Diversification, strategic investments drive growth

Buy: SRF Ltd.

Target

Motilal Oswal

FY26 was characterized by a volatile and uncertain global environment, with the geopolitical tensions in the Middle East disrupting trade flows and supply chains.

SRF Ltd. is trading above all available SMAs

SRF Ltd.

07 May 2026

2874.70

-0.51%

BP Equities Q4FY26 Result Update SRF Ltd.

Results Update: SRF Ltd.

BP Wealth

...

Number of FII/FPI investors decreased from 625 to 597 in Jun 2026 qtr

SRF Ltd.

07 May 2026

2874.70

-0.51%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q4FY26- Slowdown in Chemicals impact revenues- Revenues in Q4FY26 grew 7.5% YoY to 4,532 crore. Segment wise, Chemicals business (53% of the revenues) reported a growth of 4% YoY to 2,448.3 crore. Performance films (35% of revenues), was up 13% YoY to 1,595 crore and Technical Textiles (10% of revenues) reported an uptick of 5.3% to 482 crore. GPM, for the quarter stood at 50.5%, up 200 bps YoY. EBITDA stood at 1,026 crore, up 7% YoY, translating to margins of 22.2%, flat YoY. PAT for the quarter stood at 582 crore, up 11% YoY. For FY26, the revenues stood at...

Number of FII/FPI investors decreased from 625 to 597 in Jun 2026 qtr

SRF Ltd.

06 May 2026

2874.70

-0.51%

SRF: Q4FY26 Result Review

Buy: SRF Ltd.

Target

IDBI Capital

SRF delivered results which were surpassed our estimates. While Revenue grew by 7% YoY, EBITDA and Adjusted PAT grew by rates of 7% and 11% from a very strong base quarter in Q4FY25.The chemicals business continued to exhibit strong growth owing to higher HFC pricing and placement of higher volumes in domestic and export markets. SRF delivered on the guidance of a robust Q4FY26 performance on the back of conversion of pent up and deferred orders. Specialty Chemicals Business clocked in steady revenue growth of 16% for FY26 with margins coming in at healthy 29%. SRF is undertaking significant capex into...

Number of FII/FPI investors decreased from 625 to 597 in Jun 2026 qtr

SRF Ltd.

06 May 2026

2874.70

-0.51%

Broad-based growth across all segments

Buy: SRF Ltd.

Target

Motilal Oswal

SRF delivered a healthy performance in 4QFY26 as EBIT grew 14% YoY, led by a 5%/47%/63% YoY jump in the EBIT of Chemicals/Performance Films and Foil (PFF)/Technical Textiles Business (TTB).

SRF Ltd. is trading above all available SMAs

SRF Ltd.

04 Feb 2026

2874.70

-0.51%

SRF LTD

Buy: SRF Ltd.

Target

Geojit BNP Paribas

*over or under performance to benchmark index SRF Limited manufactures and sells textiles, chemicals, films, and polymers through four business segments: Technical, Chemicals, Packaging, and Others, with diverse...

Number of FII/FPI investors decreased from 625 to 597 in Jun 2026 qtr

SRF Ltd.

22 Jan 2026

2874.70

-0.51%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q3FY26- Chemicals Business drives growth- Revenues grew 6% YoY to 3,611.5 crore driven by the Chemicals business (49% of the revenues) which reported a growth of 22% YoY to 1,825 crore. Meanwhile performance films (36% of revenues) declined by 3% YoY to 1,342 crore and Technical Textiles (12% of revenues) reported a decline of 11% YoY for the third consecutive quarter to 453 crore. Consolidated EBITDA stood at 780 crore, up 26% YoY, translating to margins of 21%, up ~330 bps YoY driven by the chemical business EBIT which stood at 27%, up ~300 bps YoY....

SRF Ltd. has an average target of 3380.29 from 8 brokers.

SRF Ltd.

21 Jan 2026

2874.70

-0.51%

SRF Q3FY26 Result Review

Buy: SRF Ltd.

IDBI Capital

SRF delivered results which were only marginally below our estimates. While Revenue grew by 6% YoY, EBITDA and Adjusted PAT grew by impressive rates of 26% and 86%. The chemicals business continued to exhibit strong growth owing to higher HFC pricing and placement of higher volumes in domestic and export markets. Although some orders have been deferred on the agro side, the management expects to recoup majority of the same in Q4FY26. Pent up purchase orders are expected to convert in Q4FY26 leading to a robust quarter, a trend which was seen in Q4FY25 as well. Specialty Chemicals Business grew on...

SRF Ltd. is trading above all available SMAs

SRF Ltd.

21 Jan 2026

2874.70

-0.51%

BP Equities Q3FY26 Result Update SRF Ltd

Results Update: SRF Ltd.

BP Wealth

...

Number of FII/FPI investors decreased from 625 to 597 in Jun 2026 qtr

SRF Ltd.

20 Jan 2026, 12:00AM

2874.70

-0.51%

Strong performance continues in Chemical business

Buy: SRF Ltd.

Target

Motilal Oswal

SRF delivered a healthy performance in 3QFY26 as EBIT surged 25% YoY, fueled by a strong 36% YoY jump in chemical segment EBIT, despite persistent global headwinds.

SRF Ltd. is trading above all available SMAs

Is SRF Ltd. worth buying?

434 Votes:

Buy 74.42%

Sell 15.67%

Hold 9.91%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Results Update SEE REPORTS >

pdf